Predictors of axillary lymph node involvement in women with T3 breast cancers: analysis of 1988-2003 SEER data

J Surg Res. 2010 Jun 15;161(2):183-9. doi: 10.1016/j.jss.2009.08.014. Epub 2009 Sep 5.

Abstract

Background: We investigated characteristics associated with axillary lymph node (LN) status in patients with T3 breast cancers and hypothesized that LN status is an independent predictor of survival.

Methods: Characteristics associated with axillary LN metastasis among women with T3 breast cancers were identified from the 1988-2003 Surveillance, Epidemiology, and End Results (SEER) database. The primary outcome was breast cancer-specific mortality. Cox models were used to calculate adjusted hazard ratios (aHR) and 95% confidence intervals (CI).

Results: A total of 12,778 patients with T3 breast cancers were analyzed (8201 LN+, 3695 LN-, 882 unknown). LN+ patients were more likely to be <50 y, married, and have ER+/PR+, grade 3 invasive ductal cancers (P<0.01 for each). Most patients underwent mastectomy (87.4%). Post-mastectomy radiation was more commonly used in LN+ patients (P<0.01). LN+ patients had higher breast cancer-specific mortality (36.2% versus 16.4%, P<0.01) and were more likely to die during the follow-up period (aHR = 2.87, 95% CI: 2.62-3.15) compared with LN- patients.

Conclusions: Analysis of the SEER database indicated that several patient and tumor characteristics predict a higher likelihood of axillary LN involvement in patients with T3 breast cancers. LN status was an independent predictor of survival in women with T3 breast cancers.

MeSH terms

  • Adult
  • Axilla
  • Breast Neoplasms / mortality
  • Breast Neoplasms / pathology*
  • Breast Neoplasms / radiotherapy
  • Breast Neoplasms / surgery
  • Female
  • Humans
  • Lymph Nodes / pathology*
  • Lymphatic Metastasis / pathology*
  • Lymphoma / mortality
  • Lymphoma / pathology
  • Mastectomy
  • Middle Aged
  • Neoplasm Invasiveness
  • Neoplasm Staging
  • Paget's Disease, Mammary / mortality
  • Paget's Disease, Mammary / pathology
  • Patient Selection
  • Predictive Value of Tests
  • Probability
  • Receptors, Estrogen / analysis
  • Receptors, Progesterone / analysis
  • Registries
  • Retrospective Studies
  • SEER Program / organization & administration*
  • Sarcoma / mortality
  • Sarcoma / pathology
  • Survival Rate

Substances

  • Receptors, Estrogen
  • Receptors, Progesterone